Skip to content
← Back to this collection

PUBLICATIONS · 7605984

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
1995 Jul 15
First author
Rowe JM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Rowe JM
      type
      Author
    2. name
      Andersen JW
      type
      Author
    3. name
      Mazza JJ
      type
      Author
    4. name
      Bennett JM
      type
      Author
    5. name
      Paietta E
      type
      Author
    6. name
      Hayes FA
      type
      Author
    7. name
      Oette D
      type
      Author
    8. name
      Cassileth PA
      type
      Author
    9. name
      Stadtmauer EA
      type
      Author
    10. name
      Wiernik PH
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Rowe JM
      type
      Author
    2. name
      Andersen JW
      type
      Author
    3. name
      Mazza JJ
      type
      Author
    4. name
      Bennett JM
      type
      Author
    5. name
      Paietta E
      type
      Author
    6. name
      Hayes FA
      type
      Author
    7. name
      Oette D
      type
      Author
    8. name
      Cassileth PA
      type
      Author
    9. name
      Stadtmauer EA
      type
      Author
    10. name
      Wiernik PH
      type
      Author
    bibliography ids
    1. nci-bib-b736ea084404bd508b9ed4a0
    book metadata
    content sha256
    e2fccdf815ede32ac7543fc3f7051406f9a7af9148e969c2563b0c84e5518776
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:7605984
      immutable id
      pubmed:7605984@e2fccdf815ede32ac7543fc3f7051406f9a7af9148e969c2563b0c84e5518776
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      2
      name
      Blood
      nlm unique id
      7603509
      pages
      457-62
      volume
      86
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        7605984
        provenance
        batch id
        0195e80d659ca3142556
        provider
        NCBI PubMed ESummary
        record sha256
        a3d446a4508e193a1e408f2f7f9208bf0185bdd28a3c45d8188f2e71b2f8b6da
        response sha256
        021698996c455bb1930ebf197fc7e88fce61693e192449206cc5457c0644e062
        retrieved at
        2026-09-09T23:45:16.849437+00:00
        publication date
        display
        1995 Jul 15
        precision
        day
        year
        1995
        publication types
        1. Clinical Trial
        2. Clinical Trial, Phase III
        3. Journal Article
        4. Multicenter Study
        5. Randomized Controlled Trial
        6. Research Support, U.S. Gov't, P.H.S.
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/7605984/
        title
        A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

        Preserved source evidence · Not medical advice